Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trimethoprim, a sulphonamide potentiator.

× No keyword cloud information.

15 in total

1. 5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO.

Authors: B ROTH; E A FALCO; G H HITCHINGS; S R BUSHBY
Journal: J Med Pharm Chem Date: 1962-11

2. [TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE, OR (TRIM'ETHOPRIME)].

Authors: M SCHNEIDER; L SCHWARZENBERG; A CATTAN; J R SCHLUMBERGER; J L AMIEL; G MATHE
Journal: Presse Med Date: 1965-03-27 Impact factor: 1.228

3. The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum.

Authors: I M ROLLO
Journal: Br J Pharmacol Chemother Date: 1955-06

4. A study of the uptake and degradation of folic acid, citrovorum factor, aminopterin, and pyrimethamine by bacteria.

Authors: R C WOOD; G H HITCHINGS
Journal: J Biol Chem Date: 1959-09 Impact factor: 5.157

5. Successful Treatment of a Case of Proteus Septicaemia.

Authors: E W Noall; H F Sewards; P M Waterworth
Journal: Br Med J Date: 1962-10-27

6. A new medium for bacteriologic diagnosis of tuberculosis.

Authors: L R PEIZER; C SCHECTER
Journal: Am J Clin Pathol Date: 1950-07 Impact factor: 2.493

7. Studies on analogs of purines and pyrimidines.

Authors: G H HITCHINGS; G B ELION; E A FALCO; P B RUSSELL; H VANDERWERFF
Journal: Ann N Y Acad Sci Date: 1950-07-07 Impact factor: 5.691

8. Inhibitor binding analysis of dihydrofolate reductases from various species.

Authors: J J Burchall; G H Hitchings
Journal: Mol Pharmacol Date: 1965-09 Impact factor: 4.436

Review 9. Inhibition of folate biosynthesis and function as a basis for chemotherapy.

Authors: G H Hitchings; J J Burchall
Journal: Adv Enzymol Relat Areas Mol Biol Date: 1965

10. Therapeutic trial of trimethoprim as a potentiator of sulphonamides in gonorrhoea.

Authors: G W Csonka; G J Knight
Journal: Br J Vener Dis Date: 1967-09

117 in total

Review 1. Synergy of trimethoprim-sulfamethoxazole.

Authors: S R Bushby
Journal: Can Med Assoc J Date: 1975-06-14 Impact factor: 8.262

2. Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions.

Authors: M A Kielhofner
Journal: Tex Heart Inst J Date: 1990

3. Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.

Authors: Lisa Yun Song; Sara D'Souza; Karen Lam; Tina Manzhu Kang; Pamela Yeh; Jeffrey H Miller
Journal: Antimicrob Agents Chemother Date: 2015-12-28 Impact factor: 5.191

4. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.

Authors: Fumiaki Tabuchi; Yasuhiko Matsumoto; Masaki Ishii; Keita Tatsuno; Mitsuhiro Okazaki; Tomoaki Sato; Kyoji Moriya; Kazuhisa Sekimizu
Journal: J Antibiot (Tokyo) Date: 2017-02-15 Impact factor: 2.649

5. Bioavailability and pharmacokinetics of sulphadiazine, N4-acetylsulphadiazine and trimethoprim following intravenous and intramuscular administration of a sulphadiazine/trimethoprim combination in sheep.

Authors: G C Batzias; G A Delis; M Koutsoviti-Papadopoulou
Journal: Vet Res Commun Date: 2005-11 Impact factor: 2.459

6. Tuberculosis and trimethoprim-sulfamethoxazole.

Authors: Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal: Antimicrob Agents Chemother Date: 2009-06-29 Impact factor: 5.191

7. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.

Authors: S G Amyes
Journal: Antimicrob Agents Chemother Date: 1982-02 Impact factor: 5.191

Trimethoprim, a sulphonamide potentiator.